Trial Profile
The treatment combination of anti-VEGF injections, laser coagulation and cryotheraphy on patients with Coat`s disease
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 18 Apr 2017
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Retinal telangiectasis
- Focus Therapeutic Use
- 18 Apr 2017 New trial record